Cargando…
How Sweden approached the COVID‐19 pandemic: Summary and commentary on the National Commission Inquiry
AIM: Sweden initially chose a different disease prevention and control path during the pandemic than many other European countries. In June 2020, the Swedish Government established a National Commission to examine the management of COVID‐19 in Sweden. This paper summarises, and discusses, its findin...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538368/ https://www.ncbi.nlm.nih.gov/pubmed/36065136 http://dx.doi.org/10.1111/apa.16535 |
_version_ | 1784803342989393920 |
---|---|
author | Ludvigsson, Jonas F. |
author_facet | Ludvigsson, Jonas F. |
author_sort | Ludvigsson, Jonas F. |
collection | PubMed |
description | AIM: Sweden initially chose a different disease prevention and control path during the pandemic than many other European countries. In June 2020, the Swedish Government established a National Commission to examine the management of COVID‐19 in Sweden. This paper summarises, and discusses, its findings. METHODS: Three reports published by the Commission were analysed. The first focused on the care of older people during the pandemic. The second examined disease and infection transmission and control and health care and public health. The third updated the first two reports and also covered economic aspects, crisis management and public communication. RESULTS: By 25 February 2022, when the final report was published, 15 800 individuals, 1.5 per 1000 Swedish inhabitants, had died after COVID‐19. The death rates were high in spring 2020, but overall excess mortality in 2020–2021 was +0.79%, which was lower than in many other European countries. The Commission suggested that the voluntary measures that were adopted were appropriate and maintained Swedes' personal freedom during the pandemic. However, more extensive and earlier measures should have been taken, especially during the first wave. CONCLUSION: The Swedish COVID‐19 Commission felt that earlier and more extensive pandemic action should have been taken, particularly during the first wave. |
format | Online Article Text |
id | pubmed-9538368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95383682022-10-11 How Sweden approached the COVID‐19 pandemic: Summary and commentary on the National Commission Inquiry Ludvigsson, Jonas F. Acta Paediatr Review Articles AIM: Sweden initially chose a different disease prevention and control path during the pandemic than many other European countries. In June 2020, the Swedish Government established a National Commission to examine the management of COVID‐19 in Sweden. This paper summarises, and discusses, its findings. METHODS: Three reports published by the Commission were analysed. The first focused on the care of older people during the pandemic. The second examined disease and infection transmission and control and health care and public health. The third updated the first two reports and also covered economic aspects, crisis management and public communication. RESULTS: By 25 February 2022, when the final report was published, 15 800 individuals, 1.5 per 1000 Swedish inhabitants, had died after COVID‐19. The death rates were high in spring 2020, but overall excess mortality in 2020–2021 was +0.79%, which was lower than in many other European countries. The Commission suggested that the voluntary measures that were adopted were appropriate and maintained Swedes' personal freedom during the pandemic. However, more extensive and earlier measures should have been taken, especially during the first wave. CONCLUSION: The Swedish COVID‐19 Commission felt that earlier and more extensive pandemic action should have been taken, particularly during the first wave. John Wiley and Sons Inc. 2022-09-15 /pmc/articles/PMC9538368/ /pubmed/36065136 http://dx.doi.org/10.1111/apa.16535 Text en © 2022 The Author. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Review Articles Ludvigsson, Jonas F. How Sweden approached the COVID‐19 pandemic: Summary and commentary on the National Commission Inquiry |
title | How Sweden approached the COVID‐19 pandemic: Summary and commentary on the National Commission Inquiry |
title_full | How Sweden approached the COVID‐19 pandemic: Summary and commentary on the National Commission Inquiry |
title_fullStr | How Sweden approached the COVID‐19 pandemic: Summary and commentary on the National Commission Inquiry |
title_full_unstemmed | How Sweden approached the COVID‐19 pandemic: Summary and commentary on the National Commission Inquiry |
title_short | How Sweden approached the COVID‐19 pandemic: Summary and commentary on the National Commission Inquiry |
title_sort | how sweden approached the covid‐19 pandemic: summary and commentary on the national commission inquiry |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538368/ https://www.ncbi.nlm.nih.gov/pubmed/36065136 http://dx.doi.org/10.1111/apa.16535 |
work_keys_str_mv | AT ludvigssonjonasf howswedenapproachedthecovid19pandemicsummaryandcommentaryonthenationalcommissioninquiry |